Glenmark Life Sciences Ltd
company logo

Glenmark Life Sciences Ltd

Pharmaceuticals
Mid Cap

-

- (0%)


Glenmark Life Sciences Ltd Performance

-

-

-

-


-

-

-

-

-

Glenmark Life Sciences Ltd Fundamentals

10,425.84Cr

22.14

4.47

0.01

38.43

2.64%

190.35

i buttonClick here to know more about Fundamentals

Glenmark Life Sciences Ltd Financials

Glenmark Life Sciences Ltd Financialsright-arrow

Glenmark Life Sciences Ltd Shareholding Pattern

Glenmark Life Sciences Ltd Delivery and Volume

About Glenmark Life Sciences Ltd

The company was incorporated as Zorg Laboratories Private Limited', a private limited company under the Companies Act, 1956 on 23 June 2011 at Pune and was granted the certificate of incorporation by the Registrar of Companies, Maharashtra at Pune ('RoC'). Subsequently, the Company was acquired by G

Yasir Yusufali Rawjee

2011

GLS

NameDesignation
Glenn SaldanhaChairman & Non Executive Dir.
V S ManiNon Executive Director
Yasir Yusufali RawjeeManaging Director & CEO
Vinod NaikE D & Wholetime Director
Sridhar GorthiIndependent Non Exe. Director
Manju AgarwalIndependent Non Exe. Director
Taruvai Laxminarayanan EaswarIndependent Non Exe. Director
Gita NayyarIndependent Non Exe. Director
News and Events...

Similar Stocks

What's Trending

Glenmark Life Sciences Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Glenmark Life Sciences Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Glenmark Life Sciences Ltd's share price is ₹848 as of 2024-07-23.
Glenmark Life Sciences Ltd's P/E ratio is 22.14 times as of 2024-07-23.
Glenmark Life Sciences Ltd's most recent financial reports indicate a price-to-book ratio of 4.47, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Glenmark Life Sciences Ltd's market capitalization is ₹10425.84 Cr as on 2024-07-23.
The current financial records of Glenmark Life Sciences Ltd show a 22.28% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Glenmark Life Sciences Ltd's most recent financial filings, the company has a total asset value of ₹1852.15, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Glenmark Life Sciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Glenmark Life Sciences Ltd's 52-week high and low as of 2024-07-23 are ₹852.95 and ₹842.75, respectively.